Lyka Labs Ltd.
BSE: 500259 | Sector: Health care |
NSE: LYKALABS | ISIN Code: INE933A01014 |
BSE 00:00 | 26 May | 118.75 |
-1.70 (-1.41%) |
OPEN
118.10 |
HIGH
119.90 |
LOW
114.45 |
NSE 00:00 | 26 May | 118.80 |
-1.70 (-1.41%) |
OPEN
117.60 |
HIGH
119.75 |
LOW
114.50 |
OPEN | 118.10 |
PREVIOUS CLOSE | 120.45 |
VOLUME | 10345 |
52-Week high | 267.20 |
52-Week low | 50.70 |
P/E | 7.92 |
Mkt Cap.(Rs cr) | 341 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Lyka Labs Ltd. (LYKALABS) - Yearly Result
Particulars (![]() |
Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 |
Net Sales/Income From Operations | 164.35 | 62.26 | 40.74 | 41.18 | 41.68 |
Other Income | 2.72 | 2.21 | 2.60 | 2.58 | 3.36 |
Total Income | 167.07 | 64.47 | 43.34 | 43.76 | 45.04 |
Total Expenditure | 71.52 | 49.27 | 71.71 | 40.69 | 43.82 |
Operating Profit | 95.55 | 15.21 | -28.37 | 3.07 | 1.22 |
Interest | 19.92 | 25.55 | 19.01 | 5.73 | 6.13 |
Gross Profit | 75.63 | -10.35 | -47.38 | -2.66 | -4.91 |
Depreciation | 15.39 | 8.05 | 7.77 | 4.44 | 6.31 |
PBT | 60.24 | -18.40 | -55.15 | -7.10 | -11.22 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit/(Loss) | 39.90 | -14.46 | -55.39 | 1.73 | -10.84 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | -3.09 | -1.43 | -27.63 | -0.53 | 1.47 |
Profit After Exceptional Items | 42.99 | -13.03 | -27.76 | 2.26 | -12.31 |
Equity Share Capital | 28.69 | 28.69 | 28.69 | 28.14 | 28.14 |
Reserves Excluding Revaluation Reserves | 15.75 | -24.28 | 12.59 | 70.46 | 68.64 |
EPS | |||||
Basic EPS | 13.87 | -5.08 | -19.48 | 0.58 | -4.24 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices